Trials / Completed
CompletedNCT00681486
Ghrelin - A Possible Opportunity to Improve Appetite
Ghrelin - A Possible Opportunity to Improve Appetite, Nutritional State, Metabolic Integrity and Physical Functioning in Cancer Patients With Progressive Weight Loss
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Göteborg University · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to evaluate whether ghrelin treatment can improve appetite in weight losing cancer patients.
Detailed description
Randomized study with follow up evaluations each month until preterminal state. Cancer patients will be randomised to either high dose or low dose of active treatment given as daily injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ghrelin | High dose of ghrelin given as subcutaneous injection once a day for the duration of 8 weeks. |
| DRUG | Ghrelin | Low dose of ghrelin given as subcutaneous injection once a day for the duration of 8 weeks. |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2008-06-01
- Completion
- 2008-07-01
- First posted
- 2008-05-21
- Last updated
- 2009-08-21
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00681486. Inclusion in this directory is not an endorsement.